Rice University - Houston, Texas
Barbara and David Gibbs
Recreation and Wellness Center
Saturday, October 29, 2011
Dr. Gregory Burzynski
- Innovative and cutting-edge Personalized Gene-Targeted Cancer Therapy
- Customized treatment for over 50 types of malignancies
- Currently approved for Phase III Clinical Trial for Antineoplastons treatment (must meet criteria)
- Medical expertise based on over 40 years of clinical experience and research
- Concierge care centered around the patient and their families in a warm, supportive environment
For over 30 years, Dr. Burzynski’s cancer research has been inspired by the philosophy of the physician, Hippocrates, to “First, do no harm.” True to this philosophy, the treatment regimes developed by him are based on natural biochemical defense system of our body, capable of combating cancer without harming the healthy cells. The Burzynski Clinic does not believe in a “one-size-fits-all treatment” for cancer patients. Our care encompasses a personalized and customized approach based on the individual genetic “fingerprint” of each cancer. Meaning what causes and stimulates that particular patient’s cancer. Our goal is to be as sophisticated as possible when treating our cancer patients. This method reduces the use of potentially ineffective medication and leads to remarkable health improvement, saving time and money. Every day, in everything we do, we are proudly committed to these values. Patients’ health and wellbeing are most important to us. Our goal is to continue cancer research; our mission is to beat cancer.
Dr. Gregory Burzynski joined the medical team at the Burzynski Clinic in the summer of 2010. He is now the Vice President of the Burzynski Clinic and oversees many operations. Dr. Burzynski graduated from the University of Texas at Austin with a Bachelor of Science in Neurobiology and later studied medicine at the Jagiellonian University Medical College in Krakow, Poland. He finished his internal medicine residency at the University of Texas at Austin and is Board Certified in Internal Medicine. Dr. Burzynski has been involved in co-authoring publications regarding Antineoplastons. Currently, he is a member of the Texas Medical Association, Harris County Medical Association,American Medical Association, American College of Physicians and The Society of NeuroOncology. Dr. Gregory Burzynski’s goal is to optimize personal medicine at the Burzynski Clinic and continue future advancements in Antineoplaston technology.